企業プロフィール
Ensysce Biosciences 株価・ニュース・カタリスト
- ティッカー:
- ENSC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.38 USD (-5.83%)
終値
最終更新: 2026年8月17日
3.84M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ENSC closed down 5.83% at $0.3766. No new same-company headline was identified in the current news window.
企業概要
Complex-Pain Therapeutics
Ensysce Biosciences develops neuroplastogenic and opioid-based therapies for severe and complex pain. The company expanded its strategy through the acquisition of Cy Biopharma.
CY200
CY200 is an orphan-designated neuroplastogenic candidate for complex regional pain syndrome type 1. It is designed to address the underlying neurobiology of the disorder rather than only managing symptoms.
Protected Opioid Platform
Ensysce's Trypsin-Activated Abuse Protection technology keeps opioid prodrugs inactive until they reach the small intestine. PF614 applies this approach to an extended-release oxycodone product.
Overdose-Protection Program
PF614-MPAR combines abuse protection with Multi-Pill Abuse Resistance technology intended to limit oral overdose. The program has received FDA Breakthrough Therapy designation.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。